Aligned Genetics, Inc.
Research Aligned Genetics, Inc. (238120.KQ) on Bullrun: market cap KRW 35.93B. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- Ticker238120.KQ
- ExchangeKQ
- CountrySouth Korea
- SectorHealthcare
- IndustryMedical Devices
- CurrencyKRW
- Market capKRW 35.93B
- Financial periodQ2 2026
- RevenueKRW 4.35B
- Net incomeKRW 1.75B
- Free cash flowKRW 308.88M
- Gross margin74.5%
Valuation Snapshot
latest market cap is KRW 35.93B.
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-17 | KRW 35.93B | n/a | n/a | n/a |
Dividend history
About Aligned Genetics, Inc.
Aligned Genetics, Inc. offers cellular imaging and biomolecular analysis solutions worldwide. It also provides molecular diagnostic solutions for rapid results under the Genescale name; and advanced imaging and analysis solutions under the Logos Biosystems name. The company was formerly known as Logos Biosystems, Inc. and changed its name to Aligned Genetics, Inc. in September 2020. Aligned Genetics, Inc. was founded in 2008 and is headquartered in Anyang-Si, South Korea.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Aligned Genetics, Inc.'s market cap?
Aligned Genetics, Inc.'s market capitalization is KRW 35.93B.
What does Aligned Genetics, Inc. do?
Aligned Genetics, Inc. offers cellular imaging and biomolecular analysis solutions worldwide. It also provides molecular diagnostic solutions for rapid results under the Genescale name; and advanced imaging and analysis solutions under the Logos Biosystems name. The company was formerly known as Logos Biosystems, Inc. and changed its name to Aligned Genetics, Inc. in September 2020. Aligned Genetics, Inc. was founded in 2008 and is headquartered in Anyang-Si, South Korea.